Sector | Healthcare |
Industry | - |
Day Range | 145.51 | 147.30 |
52-Wk Range | 94.59 | 149.61 |
Last Close | 147.19 |
Mkt Cap (m) | 105,723.81 |
Dividend yield | 0.46% |
ISIN | US2358511028 |
Volume | 15,095,732 |
Exchange Venue | NYS |
Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.
Price/Earning | 43.55 |
Price/Book | 3.42 |
Price/Sales | 5.20 |
P/CF | 26.05 |
Rev Growth (3 year avg) | -1.10 |
EPS Growth (3 year avg) | -0.08 |
Operating Margin % | 17.11 |
Net Margin % | 13.33 |
Return on Equity | 9.72 |
Debt/Equity | 0.35 |
en 31/10/2019 |
en 31/12/2018 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Revenue (m) | 19,118 | 19,914 | 20,563 | 16,882 | 18,330 | 19,893 |
Operating Income (m) | 3,275 | 3,431 | 3,469 | 2,751 | 3,021 | 3,404 |
Net Income (m) | 2,695 | 2,598 | 3,357 | 2,554 | 2,492 | 2,651 |
Basic EPS | 3.87 | 3.70 | 4.81 | 3.69 | 3.58 | 3.78 |
Avg. Diluted Shares Outstanding (m) | 711 | 716 | 709 | 700 | 706 | 710 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Current Assets (m) | 9,114 | 9,431 | 7,837 | 6,665 | 6,850 | 7,094 |
Non Current Assets (m) | 25,559 | 27,560 | 40,386 | 38,630 | 39,799 | 40,739 |
Total Assets (m) | 34,672 | 36,992 | 48,222 | 45,295 | 46,649 | 47,833 |
Current Liabilities (m) | 4,527 | 5,396 | 6,170 | 6,874 | 4,792 | 4,842 |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 22,385 | 23,378 | 23,690 | 23,003 | 26,358 | 28,214 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Operating Cash Flows (m) | 3,585 | 3,758 | 3,802 | 3,522 | 3,478 | 4,022 |
Capital Expenditure (m) | -552 | -598 | -633 | -590 | -620 | -656 |